Screener
Cullinan Therapeutics, Inc. CGEM Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (57,254) | (75,798) | (110,951) | (130,794) |
| Other income (expense): | ||||
| Interest income | 3,648 | 5,924 | 7,746 | 12,504 |
| Other expense, net | (98) | (181) | (160) | (266) |
| Total other income | 3,550 | 5,743 | 7,586 | 12,238 |
| Net loss | $(53,704) | $(70,055) | $(103,365) | $(118,556) |
| Comprehensive income (loss): | ||||
| Net loss | $(53,704) | $(70,055) | $(103,365) | $(118,556) |
Item 1. Financial Statements.
FAQ
- What is Cullinan Therapeutics, Inc.'s other income (expense)?
- Cullinan Therapeutics, Inc. (CGEM) reported other income (expense) of -$98K in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Cullinan Therapeutics, Inc.'s other income (expense) increased by 45.9% year-over-year, from -$181K to -$98K.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s other income (expense)?
- Over 2 years (2022 to 2025), Cullinan Therapeutics, Inc.'s other income (expense) has grown at a 178.8% compound annual growth rate (CAGR), from $57K to -$443K.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Cullinan Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude